Scholars Central

Research articlePublished 26 May 2023

A Two-Step Approach-Machine Learning, Variational Autoencoder, and Weighted Gene Co-Expression Network Analysis Identify Key Signature Genes and Pathways Implicated in Active Visceral Leishmaniasis

Authors: Ram Nayan Verma, Naidu Subbarao, Gajendra Pratap Singh

Journal of Proteomics & Bioinformatics

Volume 16 · Issue 3 · Pages 1–14

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Leishmania donovani, a kinetoplastid parasite causing leishmaniasis, is an opportunistic parasitic pathogen that affects immunocompromised individuals and is a common cause of Kala-azar. Specific parasite molecules can be delivered into host epithelial cells and may act as effector molecules for intracellular parasite development. So, there is a need to develop new approaches to understanding the interaction between the host and the pathogen. In our study, we built a weighted gene co-expression network using differentially expressed genes obtained through analysis of leishmaniasis-infected patients. Our goal was to identify key signature genes and pathways associated with visceral leishmaniasis infection by network biology analysis which can identify the most influential genes in the gene coexpression interaction network. We identified five prominent genes, IFNG, SC5D, LSM1, CMC2, and SAR1B, with higher interamodular connectivity, as the key signature genes. A deep neural network model-variational autoencoder was utilized to create new features, and a support vector machine validated the key signature genes. These key signature genes are involved in various biological processes like cytokine-cytokine receptor interaction, TGF-beta signaling pathway, antigen processing and presentation, IL-17 signaling pathway, Th1 and Th2 cell differentiation, and T-cell receptor signaling pathway. Besides, we also identified 04 significant miRNAs targeted with key signature genes, including hsa-miR-340-5p, hsa-miR-325-3p, hsa-miR-182-5p, hsa-miR-1271-5p/hsa-miR-96-5p. Further, analysis of the differentially expressed genes revealed that many critical cellular responses were triggered by visceral leishmaniasis infection, including immune responses and inflammatory and cell apoptosis. We get FDA approved anti-inflammatory agents emapalumab and methylprednisolone as a re-proposed drug for leishmaniasis cure. Our study can enhance the understanding of the molecular pathogenesis of visceral leishmaniasis infection and have implications for the plan and execution of mRNA expression tools to support early diagnostics and treatment of visceral leishmania sis infection.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Proteomics & Bioinformatics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Proteomics & Bioinformatics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Ram Nayan Verma”
  • BylineArticles whose byline prints “Naidu Subbarao”
  • BylineArticles whose byline prints “Gajendra Pratap Singh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels